Executive Profile

Judith A. Hemberger Ph.D. Other Professional, AVAX Technologies Inc.

Age	Total Calculated Compensation	This person is connected to 8 Board Members in 8 different organizations across 13 different industries. See Board Relationships
65	--

Background

Dr. Judith A. Hemberger, Ph.D., Judy is a Venture Partner of Nomura Phase 4 Ventures. Dr. Hemberger serves as an Adjunct Assistant Professor at the University of Missouri, Kansas City School of Pharmacy. She served as the Chief Operating Officer of Zosano Pharma, Inc. She served as an Interim Chief Executive Officer of Zosano Pharma from July 20, 2006 to August 2007. She co-founded Pharmion Corp., and served as the Chief Operating Officer and Executive Vice President ... from August 1999 to April 1, 2006. She served as a Consultant of NeXstar Pharmaceuticals Inc., since 1997. From 1997 to 1999, She served as a Consultant to various healthcare companies. Prior to join Pharmion in 1999, she served as a Senior Vice President of Business Development and Planning of Avax Technologies Inc., from 1998 to 1999. She served as a Senior Vice President of Global Drug Regulatory Affairs of Marion Laboratories. From 1979 to 1997, she served at Hoechst Marion Roussel Inc. including as Senior Vice President of Global Regulatory Affairs from 1995 to 1997. She served as a Vice President of Global Medical Affairs and Commercial Development at Hoechst Marion Roussel Inc. from 1994 to 1995 and as its Advisory Director from 1994 to 1995. She led a number of strategic functions including Professional Education, Global Regulatory Affairs, Global Medical Affairs and Commercial Development. She has been a Director of PRA International since November 2005. She has been a Director of VasoGenix Pharmaceuticals Inc., since March 23, 2009. She has been a Director of Myogen Inc., since December 2005. She has been a Director of Renovis Inc., since July 20, 2005. She has been a Director of Watson Pharma Inc. since August 1999. She serves as a Director of Pharmaceutical Research Associates International Inc. She serves as a Director of Healthshares Inc. She has been a Non-Executive Director of Algeta ASA since April 2010. She serves as a Director of Chroma Therapeutics Ltd and Atani Ltd. She served as a Director of Zosano Pharma, Inc. She served as a Director of ZymoGenetics Inc., since March 13, 2006 and Novacea, Inc. since December 2007. She served as a Director of HealthShares Patient Care Services Exchange-Traded Fund. She served as a Director of NexStar Pharmaceuticals Inc., since 1997 prior to its merger with Gilead Sciences Inc., and Marion Merrell Dow before it merged with Hoechst Marion Roussel Inc. She served as a Director of PRA International from 1997 to 2001. She served as a Director of Cell Pathways Inc., since June 1998. She served as a Director of Marion Merrill Dow. She served as a Director of Perrigo Co., from January 24, 2003 to April 24, 2006. She served as a Director of Pharmion Corp., from August 1999 to April 1, 2006. Dr. Hemberger holds a Bachelor of Science in Biology and Chemistry from Mount St. Scholastica College (St. Benedictine College) and a Ph.D. in Pharmacology from the University of Missouri-Kansas City in 1975 and an MBA from Rockhurst College.

Corporate Headquarters Green Park House London, -- W1J 8LQ United Kingdom Phone: 44 2030 360 000 Fax: -- Board Members Memberships Director Chroma Therapeutics Ltd. Former Director Zosano Pharma, Inc. Former Director HealthShares (TM) Inc. - HealthShares Patient Care Services Index Exchange Traded Fund 1994-Present Vice President - Global Medical Affairs and Commercial Development and Advisory Director Hoechst Marion Roussel Inc. 1997-N/A Former Director and consultant NeXstar Pharmaceuticals, Inc. 1998-N/A Former Director Cell Pathways, Inc. 1999-2006 Co-Founder Pharmion LLC 1999-Present Director Watson Pharma, Inc. 2003-2006 Former Director Perrigo Company 2005-Present Director and Member of Compensation Committee Gilead Colorado, Inc. 2005-Present Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee PRA International, Inc. 2005-Present Director, Member of Audit Committee and Member of Compensation Committee Renovis Inc. 2006-2009 Former Director and Member of Compensation Committee ZymoGenetics Inc. 2007-N/A Former Director and Member of Compensation Committee Novacea, Inc. 2009-Present Director VasoGenix Pharmaceuticals, Inc. 2010-Present Non-Executive Director Algeta ASA Education MBA Rockhurst University BS Benedictine College Doctorate University of Missouri, Kansas City PhD University of Missouri, Kansas City BS Mount St Scholastica College Doctorate University of Missouri-Columbia PhD University of Missouri-Columbia Other Affiliations Cell Pathways, Inc. Gilead Colorado, Inc. NeXstar Pharmaceuticals, Inc. PRA International, Inc. Pharmion LLC Hoechst Marion Roussel Inc. Perrigo Company Watson Pharma, Inc. ZymoGenetics Inc. Renovis Inc. Chroma Therapeutics Ltd. Rockhurst University Novacea, Inc. VasoGenix Pharmaceuticals, Inc. University of Missouri-Columbia Benedictine College Algeta ASA University of Missouri, Kansas City Mount St Scholastica College Phase4 Ventures Limited Zosano Pharma, Inc. HealthShares (TM) Inc. - HealthShares Patient Care Services Index Exchange Traded Fund

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.